首页 > 最新文献

Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg最新文献

英文 中文
Risk factors and disease prevalence in 3331 personal check-ups performed in preventive medicine between 2006 and 2011. cross-sectional and follow-up study. 2006年至2011年期间在预防医学领域进行的3331次个人检查中的风险因素和疾病流行情况。横断面和随访研究。
M Keipes, A Bellucci, E Hansen

Introduction: The present data results from a retrospective analysis of 3331 check-ups made in the preventive medicine department of the "ZithaKlinik", named "ZithaGesondheetsZentrum". These check-ups are done for the employee's of several firm's and institutions. According to gender and age, several tests and examinations are performed and the results are given to the person's general practitioner or another doctor of his choice. We will present a global synthesis of all the results but also a follow-up study of persons having performed 2 check-ups or more over a 5-year period.

Population: In the cross-sectional part, the analysis is done on 3331 individual check-ups (1447 woman, 1884 men). The average age is 50.3 years +/- 11.4. In the follow-up study, 478 persons (191 women, 287 men) had at least 2 (maximum 5) check-ups in the 5-year period of our observation. Initial age was 54.1 +/- 10.9 years for woman and 51.4 +/- 11.4 for men, respectively 56.4 +/- 10.9 and 53.7+/- 11.2 at their last check-up.

Results: An alarming number of persons present with a weight or obesity problem (according to age ranging from 22.0% overweight and 7.3% obese from 18-29 years, respectively 37.5% and 11.3% from 30-49 years, finally 44.0% and 20.6% in the range 50-69 years). Associated risk factors and pathologies (Hypertension, Dyslipidemia, NASH, diabetes type 2 and complete metabolic syndromes) are extremely frequent and getting more so with growing age. Furthermore, physical activity is insufficient in grossly 2/3 of the studied population. The only positive point is a tendency of decreasing tobacco use in all age groups. The follow-up study is frustrating because most of the examined criteria get worse in-between check-ups instead of getting better with changes in lifestyle in an informed population.

Conclusions: Asymptomatic diseases or risk factors for non-communicable diseases are extremely frequent in the population examined. The follow-up data shows that huge parts of this group are not sufficiently conscientious of their problems to act up and change their life-style or seek adapted pharmacological prevention. Absolute number of risk factors (prevalence) or pathologies rise evidently with age but incidence (newly discovered pathologies after a first, second or a record of 21 check-ups with our services) rises less. Life-style changes are rare or insufficient to change the pathological value back to normal or therapeutically range. Even with several biases (retrospective design, selection bias, ...) our study puts similar problems forward in the population as ORISCAV. The astonishing (better than national records) results in tobacco use is probably due to a selection of more health-oriented patients and of a higher socio-educative-economic level. Alcohol abuse was very low but probably due to inadequate screening methods. A better health promotion advocating healthier

本研究的数据来自于对“ZithaKlinik”预防医学部门3331次体检的回顾性分析,名为“ZithaGesondheetsZentrum”。这些检查是为几家公司和机构的员工做的。根据性别和年龄,进行一些测试和检查,并将结果交给个人的全科医生或他选择的其他医生。我们将对所有结果进行综合分析,并对在5年内进行2次或以上检查的患者进行随访研究。人口:在横断面部分,分析了3331个个体检查(1447名女性,1884名男性)。平均年龄为50.3岁±11.4岁。在随访研究中,478人(191名女性,287名男性)在我们观察的5年期间至少进行了2次(最多5次)检查。女性的初始年龄为54.1 +/- 10.9岁,男性为51.4 +/- 11.4岁,最后一次体检时分别为56.4 +/- 10.9岁和53.7+/- 11.2岁。结果:存在体重或肥胖问题的人数惊人(按年龄划分,18-29岁超重22.0%,肥胖7.3%,30-49岁分别为37.5%和11.3%,50-69岁分别为44.0%和20.6%)。相关的危险因素和病理(高血压、血脂异常、NASH、2型糖尿病和完全代谢综合征)非常频繁,并且随着年龄的增长而增加。此外,大约三分之二的被研究人群缺乏体育锻炼。唯一积极的一点是,所有年龄组的烟草使用都有减少的趋势。后续研究令人沮丧,因为在知情人群中,大多数被检查的标准在两次检查之间变得更糟,而不是随着生活方式的改变而变得更好。结论:无症状疾病或非传染性疾病的危险因素在调查人群中极为常见。后续数据显示,这一群体中的很大一部分人对自己的问题没有足够的责任心,没有采取行动,改变他们的生活方式,或者寻求适当的药物预防。危险因素(患病率)或病理的绝对数量随年龄明显上升,但发病率(第一次、第二次或21次体检后新发现的病理)上升较少。生活方式的改变很少或不足以使病理值恢复到正常或治疗范围。即使存在一些偏差(回顾性设计、选择偏差……),我们的研究也在人群中提出了与ORISCAV相似的问题。烟草使用的惊人结果(好于全国记录)可能是由于选择了更多注重健康的患者和更高的社会教育经济水平。酒精滥用非常低,但可能是由于筛查方法不充分。提倡更健康生活的更好的健康促进必须与更好的沟通和新的激励工具联系起来。慢性非传染性疾病患者的治疗性教育将是近期的挑战,因为由于人口老龄化和个人生活方式恶化,慢性非传染性疾病的发病率上升。在这项任务中,不仅要在个人层面(保健团队与患者个人)作出努力,而且还要在国家层面(建立由多专业团队对患者进行教育的法律框架,因为邻国已经有这样的团队)作出努力。
{"title":"Risk factors and disease prevalence in 3331 personal check-ups performed in preventive medicine between 2006 and 2011. cross-sectional and follow-up study.","authors":"M Keipes,&nbsp;A Bellucci,&nbsp;E Hansen","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>The present data results from a retrospective analysis of 3331 check-ups made in the preventive medicine department of the \"ZithaKlinik\", named \"ZithaGesondheetsZentrum\". These check-ups are done for the employee's of several firm's and institutions. According to gender and age, several tests and examinations are performed and the results are given to the person's general practitioner or another doctor of his choice. We will present a global synthesis of all the results but also a follow-up study of persons having performed 2 check-ups or more over a 5-year period.</p><p><strong>Population: </strong>In the cross-sectional part, the analysis is done on 3331 individual check-ups (1447 woman, 1884 men). The average age is 50.3 years +/- 11.4. In the follow-up study, 478 persons (191 women, 287 men) had at least 2 (maximum 5) check-ups in the 5-year period of our observation. Initial age was 54.1 +/- 10.9 years for woman and 51.4 +/- 11.4 for men, respectively 56.4 +/- 10.9 and 53.7+/- 11.2 at their last check-up.</p><p><strong>Results: </strong>An alarming number of persons present with a weight or obesity problem (according to age ranging from 22.0% overweight and 7.3% obese from 18-29 years, respectively 37.5% and 11.3% from 30-49 years, finally 44.0% and 20.6% in the range 50-69 years). Associated risk factors and pathologies (Hypertension, Dyslipidemia, NASH, diabetes type 2 and complete metabolic syndromes) are extremely frequent and getting more so with growing age. Furthermore, physical activity is insufficient in grossly 2/3 of the studied population. The only positive point is a tendency of decreasing tobacco use in all age groups. The follow-up study is frustrating because most of the examined criteria get worse in-between check-ups instead of getting better with changes in lifestyle in an informed population.</p><p><strong>Conclusions: </strong>Asymptomatic diseases or risk factors for non-communicable diseases are extremely frequent in the population examined. The follow-up data shows that huge parts of this group are not sufficiently conscientious of their problems to act up and change their life-style or seek adapted pharmacological prevention. Absolute number of risk factors (prevalence) or pathologies rise evidently with age but incidence (newly discovered pathologies after a first, second or a record of 21 check-ups with our services) rises less. Life-style changes are rare or insufficient to change the pathological value back to normal or therapeutically range. Even with several biases (retrospective design, selection bias, ...) our study puts similar problems forward in the population as ORISCAV. The astonishing (better than national records) results in tobacco use is probably due to a selection of more health-oriented patients and of a higher socio-educative-economic level. Alcohol abuse was very low but probably due to inadequate screening methods. A better health promotion advocating healthier ","PeriodicalId":72476,"journal":{"name":"Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31197682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Taste preference and psychopathology. 味觉偏好与精神病理学。
G A Aguayo, M T Vaillant, C Arendt, S Bachim, C B Pull

Objective: Excessive food intake has been linked to many factors including taste preference and the presence of psychopathology. The purpose of this study was to investigate the association between sweet and salty taste preference and psychopathology in patients with severe obesity.

Methods: A consecutive series of patients applying for bariatric surgery was recruited for the study. Taste preference was self-reported. Psychopathology was assessed using the revised version of the Minnesota Multiphasic Personality Inventory-2 (MMPI-2). 190 patients were included in the study.

Results: In comparison with patients who had salty taste preference, patients with sweet taste preference had significantly higher elevations on the depression (OD: 4.090, p = 0.010) and the hysteria (OD: 2.951, p = 0.026) clinical scales of the MMPI-2.

Conclusion: The results suggest the presence of an association between taste preference and psychopathology. The findings may be of interest for clinicians who are involved in the treatment of obesity. In particular, they may wish to pay increased attention to patients with sweet taste preference or who have a strong attraction for both sweet and salty foods, in order to detect psychopathology and to adapt the treatment.

目的:过多的食物摄入与许多因素有关,包括味觉偏好和精神病理的存在。本研究旨在探讨重度肥胖患者的甜味和咸味偏好与精神病理之间的关系。方法:连续招募一系列申请减肥手术的患者进行研究。口味偏好是自我报告的。精神病理学采用明尼苏达多相人格量表-2 (MMPI-2)的修订版进行评估。190名患者参与了这项研究。结果:与咸味偏好患者相比,甜味偏好患者在抑郁(OD: 4.090, p = 0.010)和歇斯底里(OD: 2.951, p = 0.026) MMPI-2临床量表上的升高明显高于咸味偏好患者。结论:结果表明味觉偏好与精神病理之间存在关联。研究结果可能会引起参与肥胖治疗的临床医生的兴趣。特别是,他们可能希望增加对甜味偏好或对甜咸食物都有强烈吸引力的患者的关注,以便发现精神病理并适应治疗。
{"title":"Taste preference and psychopathology.","authors":"G A Aguayo,&nbsp;M T Vaillant,&nbsp;C Arendt,&nbsp;S Bachim,&nbsp;C B Pull","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Excessive food intake has been linked to many factors including taste preference and the presence of psychopathology. The purpose of this study was to investigate the association between sweet and salty taste preference and psychopathology in patients with severe obesity.</p><p><strong>Methods: </strong>A consecutive series of patients applying for bariatric surgery was recruited for the study. Taste preference was self-reported. Psychopathology was assessed using the revised version of the Minnesota Multiphasic Personality Inventory-2 (MMPI-2). 190 patients were included in the study.</p><p><strong>Results: </strong>In comparison with patients who had salty taste preference, patients with sweet taste preference had significantly higher elevations on the depression (OD: 4.090, p = 0.010) and the hysteria (OD: 2.951, p = 0.026) clinical scales of the MMPI-2.</p><p><strong>Conclusion: </strong>The results suggest the presence of an association between taste preference and psychopathology. The findings may be of interest for clinicians who are involved in the treatment of obesity. In particular, they may wish to pay increased attention to patients with sweet taste preference or who have a strong attraction for both sweet and salty foods, in order to detect psychopathology and to adapt the treatment.</p>","PeriodicalId":72476,"journal":{"name":"Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31197680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of an excess of Salmonella enteritidis phage type 14b and MLVA type 4-7-3-13-10-2-2 in Luxembourg, Belgium and Germany during 2010. 2010年卢森堡、比利时和德国肠炎沙门氏菌噬菌体14b型和MLVA型过量调查
J Mossong, C Ragimbeau, J Schuh, P Weicherding, R Peetso, C Wildemauwe, H Imberechts, W Rabsch, S Bertrand

We investigated an increase of human cases of Salmonella Enteritidis occurring from August until November 2010 in Belgium, Luxembourg and Germany involving an estimated three hundred laboratory confirmed cases. Molecular typing indicated that the increase in Luxembourg and Belgium was due a particular strain having phage type 14b, MLVA pattern 4-7-3-13-10-2-2 and fully susceptible to the Enternet panel of antibiotics. MLVA and phage typing were found to have similar discriminatory power on a collection of 40 Belgian and Luxembourg strains isolated during 2010. Epidemiological investigations in Luxembourg suggested eggs as a possible source for some cases, although supermarket eggs tested were negative. No other EU countries observed a substantial increase of cases, although three smaller outbreaks in Germany were also due to a strain with the same phage type and MLVA pattern. In 2010 the EU directive banning battery cages came into force in Germany followed by a dioxin food scare incident. Given that the EU Laying Hens Directive will come into force across all Member States in 2012, a closer monitoring of Salmonella contamination of imported eggs at retail and wholesale level is recommended.

我们调查了2010年8月至11月在比利时、卢森堡和德国发生的肠炎沙门氏菌人间病例增加,涉及约300例实验室确诊病例。分子分型表明,卢森堡和比利时的增加是由于一种特殊的菌株,其噬菌体类型为14b, MLVA模式为4-7-3-13-10-2-2,对抗生素的Enternet面板完全敏感。在2010年分离的40株比利时和卢森堡菌株中发现MLVA和噬菌体分型具有相似的歧视力。卢森堡的流行病学调查表明,鸡蛋可能是一些病例的来源,尽管超市鸡蛋检测呈阴性。其他欧盟国家没有观察到病例大幅增加,尽管德国发生的三次较小的疫情也是由具有相同噬菌体类型和MLVA模式的菌株引起的。2010年,欧盟禁止电池笼的指令在德国生效,随后发生了二恶英食品恐慌事件。鉴于欧盟蛋鸡指令将于2012年在所有成员国生效,建议在零售和批发层面对进口鸡蛋的沙门氏菌污染进行更密切的监测。
{"title":"Investigation of an excess of Salmonella enteritidis phage type 14b and MLVA type 4-7-3-13-10-2-2 in Luxembourg, Belgium and Germany during 2010.","authors":"J Mossong,&nbsp;C Ragimbeau,&nbsp;J Schuh,&nbsp;P Weicherding,&nbsp;R Peetso,&nbsp;C Wildemauwe,&nbsp;H Imberechts,&nbsp;W Rabsch,&nbsp;S Bertrand","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We investigated an increase of human cases of Salmonella Enteritidis occurring from August until November 2010 in Belgium, Luxembourg and Germany involving an estimated three hundred laboratory confirmed cases. Molecular typing indicated that the increase in Luxembourg and Belgium was due a particular strain having phage type 14b, MLVA pattern 4-7-3-13-10-2-2 and fully susceptible to the Enternet panel of antibiotics. MLVA and phage typing were found to have similar discriminatory power on a collection of 40 Belgian and Luxembourg strains isolated during 2010. Epidemiological investigations in Luxembourg suggested eggs as a possible source for some cases, although supermarket eggs tested were negative. No other EU countries observed a substantial increase of cases, although three smaller outbreaks in Germany were also due to a strain with the same phage type and MLVA pattern. In 2010 the EU directive banning battery cages came into force in Germany followed by a dioxin food scare incident. Given that the EU Laying Hens Directive will come into force across all Member States in 2012, a closer monitoring of Salmonella contamination of imported eggs at retail and wholesale level is recommended.</p>","PeriodicalId":72476,"journal":{"name":"Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31197685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The general practitioner faced with memory problems in the aged patient in Luxembourg: a study of the management employed, the experience of the physicians and the perception of the specific treatment]. [全科医生面对卢森堡老年患者的记忆问题:对所采用的管理、医生的经验和对具体治疗的看法的研究]。
C Gondoin, F Lévy, D Tirmarche

Memory impairments are common in elderly. General practitioners are in first line to detect and manage these troubles, for which many countries published recommendations. For Alzheimer disease there are currently four treatments, none of which is healing. Some countries limited the first prescription of those medicines to specialists whereas in Luxembourg, every practitioner is allowed to prescribe them, but has to ask health insurance first. Consequently, it is important that general practitioners know what to do. The aim of our paper is to study the management done by the general practitioners in Luxembourg, the way they feel about it and the way they see the specific medicines for Alzheimer disease. Therefore, we have sent a questionnaire to every general practitioner in Luxembourg. We found that 87% of the practitioners realize at least one cognitive impairment test. More than half of them check for depression and 22.6% also add an autonomy assessment scale, even though all these tests are done by the dependence insurance. The involvement of general practitioners in the diagnosis of dementia is important as more than half of them have a statistically adequate number of demented patients. About two third of the practitioners do systematically start a specific medicine for Alzheimer disease. The management of cognitive impairment is difficult for general practitioners of Luxembourg, particularly the disclosure of diagnosis and management of behavioural and psychological symptoms.

记忆障碍在老年人中很常见。全科医生处于发现和处理这些问题的第一线,许多国家为此发表了建议。对于阿尔茨海默病,目前有四种治疗方法,但没有一种能治愈。一些国家将这些药物的首次处方限制在专科医生,而在卢森堡,每个开业医生都可以开处方,但必须首先询问健康保险。因此,全科医生知道该怎么做是很重要的。我们论文的目的是研究卢森堡全科医生的管理方式,他们对此的感受以及他们对治疗阿尔茨海默病的特定药物的看法。因此,我们向卢森堡的每一位全科医生发了一份调查问卷。我们发现87%的从业人员了解至少一项认知障碍测试。其中一半以上的人检查抑郁症,22.6%的人还增加了自主性评估量表,尽管所有这些测试都是由依赖保险完成的。全科医生参与痴呆症的诊断是很重要的,因为超过一半的人有统计上足够数量的痴呆症患者。大约三分之二的医生确实系统地开始了针对阿尔茨海默病的特定药物。认知障碍的管理对卢森堡的全科医生来说是困难的,特别是披露诊断和管理行为和心理症状。
{"title":"[The general practitioner faced with memory problems in the aged patient in Luxembourg: a study of the management employed, the experience of the physicians and the perception of the specific treatment].","authors":"C Gondoin,&nbsp;F Lévy,&nbsp;D Tirmarche","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Memory impairments are common in elderly. General practitioners are in first line to detect and manage these troubles, for which many countries published recommendations. For Alzheimer disease there are currently four treatments, none of which is healing. Some countries limited the first prescription of those medicines to specialists whereas in Luxembourg, every practitioner is allowed to prescribe them, but has to ask health insurance first. Consequently, it is important that general practitioners know what to do. The aim of our paper is to study the management done by the general practitioners in Luxembourg, the way they feel about it and the way they see the specific medicines for Alzheimer disease. Therefore, we have sent a questionnaire to every general practitioner in Luxembourg. We found that 87% of the practitioners realize at least one cognitive impairment test. More than half of them check for depression and 22.6% also add an autonomy assessment scale, even though all these tests are done by the dependence insurance. The involvement of general practitioners in the diagnosis of dementia is important as more than half of them have a statistically adequate number of demented patients. About two third of the practitioners do systematically start a specific medicine for Alzheimer disease. The management of cognitive impairment is difficult for general practitioners of Luxembourg, particularly the disclosure of diagnosis and management of behavioural and psychological symptoms.</p>","PeriodicalId":72476,"journal":{"name":"Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30782420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The OPTIMISE study (Optimal Type 2 Diabetes Management Including Benchmarking and Standard Treatment]. Results for Luxembourg]. OPTIMISE研究(优化2型糖尿病管理,包括基准和标准治疗)。卢森堡的结果]。
G Michel

The OPTIMISE study (NCT00681850) has been run in six European countries, including Luxembourg, to prospectively assess the effect of benchmarking on the quality of primary care in patients with type 2 diabetes, using major modifiable vascular risk factors as critical quality indicators. Primary care centers treating type 2 diabetic patients were randomized to give standard care (control group) or standard care with feedback benchmarked against other centers in each country (benchmarking group). Primary endpoint was percentage of patients in the benchmarking group achieving pre-set targets of the critical quality indicators: glycated hemoglobin (HbAlc), systolic blood pressure (SBP) and low-density lipoprotein (LDL) cholesterol after 12 months follow-up. In Luxembourg, in the benchmarking group, more patients achieved target for SBP (40.2% vs. 20%) and for LDL-cholesterol (50.4% vs. 44.2%). 12.9% of patients in the benchmarking group met all three targets compared with patients in the control group (8.3%). In this randomized, controlled study, benchmarking was shown to be an effective tool for improving critical quality indicator targets, which are the principal modifiable vascular risk factors in diabetes type 2.

OPTIMISE研究(NCT00681850)已在包括卢森堡在内的6个欧洲国家开展,以主要可改变的血管危险因素作为关键质量指标,前瞻性评估基准对2型糖尿病患者初级保健质量的影响。治疗2型糖尿病患者的初级保健中心被随机分为标准治疗组(对照组)或标准治疗组(参照每个国家其他中心的反馈)。主要终点是基准组患者在12个月随访后达到预先设定的关键质量指标目标的百分比:糖化血红蛋白(HbAlc),收缩压(SBP)和低密度脂蛋白(LDL)胆固醇。在卢森堡,在基准组中,更多的患者达到了收缩压(40.2%对20%)和低密度脂蛋白胆固醇(50.4%对44.2%)的目标。与对照组(8.3%)相比,基准组中12.9%的患者达到了所有三个目标。在这项随机对照研究中,基准测试被证明是改善关键质量指标目标的有效工具,这些指标是2型糖尿病主要可改变的血管危险因素。
{"title":"[The OPTIMISE study (Optimal Type 2 Diabetes Management Including Benchmarking and Standard Treatment]. Results for Luxembourg].","authors":"G Michel","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The OPTIMISE study (NCT00681850) has been run in six European countries, including Luxembourg, to prospectively assess the effect of benchmarking on the quality of primary care in patients with type 2 diabetes, using major modifiable vascular risk factors as critical quality indicators. Primary care centers treating type 2 diabetic patients were randomized to give standard care (control group) or standard care with feedback benchmarked against other centers in each country (benchmarking group). Primary endpoint was percentage of patients in the benchmarking group achieving pre-set targets of the critical quality indicators: glycated hemoglobin (HbAlc), systolic blood pressure (SBP) and low-density lipoprotein (LDL) cholesterol after 12 months follow-up. In Luxembourg, in the benchmarking group, more patients achieved target for SBP (40.2% vs. 20%) and for LDL-cholesterol (50.4% vs. 44.2%). 12.9% of patients in the benchmarking group met all three targets compared with patients in the control group (8.3%). In this randomized, controlled study, benchmarking was shown to be an effective tool for improving critical quality indicator targets, which are the principal modifiable vascular risk factors in diabetes type 2.</p>","PeriodicalId":72476,"journal":{"name":"Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30782423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive relevance of clinical scores and inflammatory parameters in secondary peritonitis. 继发性腹膜炎的临床评分和炎症参数的预测相关性。
Nikolaus P Zügel, Martin Kox, Michael Lichtwark-Aschoff, Cornelia Gippner-Steppert, Marianne Jochum

Hypothesis: To measure and evaluate clinical scores and various inflammation parameters for providing a better outcome assessment of patients with secondary peritonitis.

Design: Prospective study.

Setting: ICU of a university and a university affiliated hospital.

Patients: Fifty-six patients with severe secondary peritonitis were enrolled in this study executed within 4 years.

Measurements and main results: Blood samples were taken preoperatively and 2, 6, 8, 12, 18, 24, 30, 36, 42 and 48 hours post operation, thereafter every 12th hour until day 5 respectively once daily until day 14. Etiology of peritonitis, clinical score systems (APACHE II, MOF and SOFA), and 27 mainly with activity tests or enzyme-immunoassays measurable inflammation parameters were simultaneously analyzed and stratified into lethal outcome (n = 11) or survival (n = 45), respectively. The etiological distribution of peritonitis was identical among both groups. Proportion of intraperitoneal fungi, E. coli, and bacteroids was substantially higher during the primary operation in the group with lethal outcome. With increasing significance initial and follow-up APACHE II, MOF and SOFA scores provided higher values in this group. Various plasma/serum parameters of hemostasis, leukocyte proteolytic system, acute phase reaction, cytokine system, cell adhesion, opsonization, and main organ functions showed significantly different values between both groups at the preoperative stage and/or during observation period I (day 0-4). Logistic regression analysis revealed the SOFA score and neopterin concentration as the combination with the best sensitivity (63.6%) and specificity (93.2%) for predicting the patients' survival even at the preoperative stage. For the observation period I, the combination of SOFA score and TNF receptor II showed the highest predictive sensitivity (72.7%) and specificity (95.6%).

Conclusion: Evaluation of the severity of secondary peritonitis using a scoring system with high prognostic relevance could conceivably result in an earlier and adequate application of intensive care such as hemofiltration, administration of immunoglobulins and serial abdominal lavage to improve successful outcome.

假设:测量和评估临床评分和各种炎症参数,为继发性腹膜炎患者提供更好的预后评估。设计:前瞻性研究。单位:某高校ICU及某高校附属医院。患者:56例严重继发性腹膜炎患者在4年内被纳入本研究。测量方法及主要结果:术前及术后2、6、8、12、18、24、30、36、42、48 h采血,术后每12 h采血一次,至第5天,每日1次,至第14天。同时分析腹膜炎的病因、临床评分系统(APACHE II、MOF和SOFA)和27例主要采用活性试验或酶免疫测定法测量炎症参数的患者,并将其分为致死结局(n = 11)和生存结局(n = 45)。两组患者腹膜炎的病因分布相同。初次手术时,腹腔内真菌、大肠杆菌和类杆菌的比例明显高于死亡组。随着APACHE II初始和随访的意义增加,MOF和SOFA评分在该组中提供了更高的值。两组患者术前和(或)观察第1期(0 ~ 4 d)止血、白细胞蛋白水解系统、急性期反应、细胞因子系统、细胞粘附、调理、主要脏器功能等血浆/血清各项指标差异有统计学意义。Logistic回归分析显示,SOFA评分与新蝶呤浓度的结合在预测患者术前生存方面具有最佳的敏感性(63.6%)和特异性(93.2%)。在观察期I, SOFA评分与TNF受体II联合预测敏感性最高(72.7%),特异性最高(95.6%)。结论:使用具有高预后相关性的评分系统来评估继发性腹膜炎的严重程度,可能会导致更早和充分的重症监护,如血液过滤、免疫球蛋白的使用和连续的腹腔灌洗,以提高成功的结果。
{"title":"Predictive relevance of clinical scores and inflammatory parameters in secondary peritonitis.","authors":"Nikolaus P Zügel,&nbsp;Martin Kox,&nbsp;Michael Lichtwark-Aschoff,&nbsp;Cornelia Gippner-Steppert,&nbsp;Marianne Jochum","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Hypothesis: </strong>To measure and evaluate clinical scores and various inflammation parameters for providing a better outcome assessment of patients with secondary peritonitis.</p><p><strong>Design: </strong>Prospective study.</p><p><strong>Setting: </strong>ICU of a university and a university affiliated hospital.</p><p><strong>Patients: </strong>Fifty-six patients with severe secondary peritonitis were enrolled in this study executed within 4 years.</p><p><strong>Measurements and main results: </strong>Blood samples were taken preoperatively and 2, 6, 8, 12, 18, 24, 30, 36, 42 and 48 hours post operation, thereafter every 12th hour until day 5 respectively once daily until day 14. Etiology of peritonitis, clinical score systems (APACHE II, MOF and SOFA), and 27 mainly with activity tests or enzyme-immunoassays measurable inflammation parameters were simultaneously analyzed and stratified into lethal outcome (n = 11) or survival (n = 45), respectively. The etiological distribution of peritonitis was identical among both groups. Proportion of intraperitoneal fungi, E. coli, and bacteroids was substantially higher during the primary operation in the group with lethal outcome. With increasing significance initial and follow-up APACHE II, MOF and SOFA scores provided higher values in this group. Various plasma/serum parameters of hemostasis, leukocyte proteolytic system, acute phase reaction, cytokine system, cell adhesion, opsonization, and main organ functions showed significantly different values between both groups at the preoperative stage and/or during observation period I (day 0-4). Logistic regression analysis revealed the SOFA score and neopterin concentration as the combination with the best sensitivity (63.6%) and specificity (93.2%) for predicting the patients' survival even at the preoperative stage. For the observation period I, the combination of SOFA score and TNF receptor II showed the highest predictive sensitivity (72.7%) and specificity (95.6%).</p><p><strong>Conclusion: </strong>Evaluation of the severity of secondary peritonitis using a scoring system with high prognostic relevance could conceivably result in an earlier and adequate application of intensive care such as hemofiltration, administration of immunoglobulins and serial abdominal lavage to improve successful outcome.</p>","PeriodicalId":72476,"journal":{"name":"Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29909307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemokine receptor 5 polymorphism in myocardial infarction patients from Luxembourg. 卢森堡心肌梗死患者趋化因子受体5多态性
Sophie Rodius, Christine Lambert, Carole Devaux, Jean-Claude Schmit, Yvan Devaux, Daniel R Wagner

Background: The CC-chemokine receptor 5 (CCR5) is regulating inflammatory pathways and may thus be implicated in the development and progression of heart failure (HF). A 32 base pair deletion of the ccr5 gene, called CCR5delta32, prevents the expression of CCR5 at the cell surface. We analyzed the association between the CCR5delta32 deletion and the risk and severity of myocardial infarction (MI) in a cohort of patients from Luxembourg.

Methods: Using TaqMan allelic discrimination assay, we genotyped a total of 1080 patients undergoing coronary angiography. This population contained 3 groups of patients: controls with atypical chest pain, abnormal stress testing but normal coronary angiography (n = 154), patients with angina who underwent uncomplicated primary coronary intervention (n = 230), and patients with acute MI (n = 696). In MI patients, left ventricular ejection fraction (LVEF) was determined 1-month after MI with echocardiography.

Results: The frequency of the CCR5delta32 deletion was 16.3% in the global population, and was similar between controls, patients with angina and MI patients. The deletion was not associated with variations of plasma levels of creatine phosphokinase and troponin T, nor it was associated with LVEF, New York Heart Association class or 2-year mortality. The frequency of the deletion was comparable between MI patients with LV dysfunction (EF < or = 40%, n = 82) and no LV dysfunction (EF > 40%, n = 402).

Conclusions: The frequency of the CCR5delta32 deletion in Luxembourg is similar to that observed in other European countries and is not associated with the risk of developing MI and LV dysfunction.

背景:cc趋化因子受体5 (CCR5)调节炎症途径,因此可能与心力衰竭(HF)的发生和进展有关。ccr5基因的32个碱基对缺失,被称为CCR5delta32,阻止了ccr5在细胞表面的表达。我们分析了来自卢森堡的一组患者CCR5delta32缺失与心肌梗死(MI)风险和严重程度之间的关系。方法:采用TaqMan等位基因鉴别法对1080例冠状动脉造影患者进行基因分型。该人群包含3组患者:非典型胸痛、应激试验异常但冠状动脉造影正常的对照组(n = 154)、心绞痛患者(n = 230)和急性心肌梗死患者(n = 696)。心肌梗死患者在心肌梗死后1个月用超声心动图测定左心室射血分数(LVEF)。结果:CCR5delta32缺失的频率在全球人群中为16.3%,在对照组、心绞痛患者和心肌梗死患者之间相似。缺失与血浆肌酸磷酸激酶和肌钙蛋白T水平的变化无关,也与LVEF、纽约心脏协会分级或2年死亡率无关。有左室功能障碍的心肌梗死患者(EF <或= 40%,n = 82)和无左室功能障碍的心肌梗死患者(EF > 40%, n = 402)的基因缺失频率相当。结论:卢森堡CCR5delta32缺失的频率与其他欧洲国家相似,与发生心肌梗死和左室功能障碍的风险无关。
{"title":"Chemokine receptor 5 polymorphism in myocardial infarction patients from Luxembourg.","authors":"Sophie Rodius,&nbsp;Christine Lambert,&nbsp;Carole Devaux,&nbsp;Jean-Claude Schmit,&nbsp;Yvan Devaux,&nbsp;Daniel R Wagner","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The CC-chemokine receptor 5 (CCR5) is regulating inflammatory pathways and may thus be implicated in the development and progression of heart failure (HF). A 32 base pair deletion of the ccr5 gene, called CCR5delta32, prevents the expression of CCR5 at the cell surface. We analyzed the association between the CCR5delta32 deletion and the risk and severity of myocardial infarction (MI) in a cohort of patients from Luxembourg.</p><p><strong>Methods: </strong>Using TaqMan allelic discrimination assay, we genotyped a total of 1080 patients undergoing coronary angiography. This population contained 3 groups of patients: controls with atypical chest pain, abnormal stress testing but normal coronary angiography (n = 154), patients with angina who underwent uncomplicated primary coronary intervention (n = 230), and patients with acute MI (n = 696). In MI patients, left ventricular ejection fraction (LVEF) was determined 1-month after MI with echocardiography.</p><p><strong>Results: </strong>The frequency of the CCR5delta32 deletion was 16.3% in the global population, and was similar between controls, patients with angina and MI patients. The deletion was not associated with variations of plasma levels of creatine phosphokinase and troponin T, nor it was associated with LVEF, New York Heart Association class or 2-year mortality. The frequency of the deletion was comparable between MI patients with LV dysfunction (EF < or = 40%, n = 82) and no LV dysfunction (EF > 40%, n = 402).</p><p><strong>Conclusions: </strong>The frequency of the CCR5delta32 deletion in Luxembourg is similar to that observed in other European countries and is not associated with the risk of developing MI and LV dysfunction.</p>","PeriodicalId":72476,"journal":{"name":"Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29909306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lung cancer statistics in Luxembourg from 1981 to 2008. 1981年至2008年卢森堡肺癌统计数据。
P G Thill, P Goswami, G Berchem, B Domon

Lung cancer is the leading cause of cancer-related death in the world and in Luxembourg. As a part of "The health science initiative focused on personalized medicine", Luxembourg aims to participate by developing diagnostics to improve the detection and treatment of lung cancer. In line with this objective, this study made a review of evolution of lung cancer in Luxembourg from 1981 to 2008 and compared this statistics to the situation in the Nordic countries, Europe in general and the World. Incidence data of the national morphological tumour registry and mortality data of the service of statistics of the national ministry of health is depicted in charts with trend lines, in the framework of a statistical evaluation of relevant parameters. The data indicate that while male lung cancer incidence decreased in Luxembourg, the incidence in women and its mortality have doubled over the 28-year span considered. Notwithstanding this increase, the female lung cancer incidence and mortality remain low compared to the Nordic countries and Europe. Interestingly, the study also potentially suggests that the lung cancer pattern follows the smoking pattern in incidence and mortality.

肺癌是世界上和卢森堡癌症相关死亡的主要原因。作为"注重个性化医疗的卫生科学倡议"的一部分,卢森堡的目标是通过开发诊断方法来改善肺癌的检测和治疗。根据这一目标,本研究回顾了1981年至2008年卢森堡肺癌的演变,并将这一统计数据与北欧国家、欧洲和世界的情况进行了比较。在对相关参数进行统计评估的框架内,国家形态肿瘤登记处的发病率数据和国家卫生部统计处的死亡率数据以带有趋势线的图表表示。数据表明,虽然卢森堡的男性肺癌发病率有所下降,但在所考虑的28年期间,女性的发病率及其死亡率翻了一番。尽管有所增加,但与北欧国家和欧洲相比,女性肺癌发病率和死亡率仍然较低。有趣的是,该研究还潜在地表明,肺癌的发病率和死亡率与吸烟的模式相似。
{"title":"Lung cancer statistics in Luxembourg from 1981 to 2008.","authors":"P G Thill,&nbsp;P Goswami,&nbsp;G Berchem,&nbsp;B Domon","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Lung cancer is the leading cause of cancer-related death in the world and in Luxembourg. As a part of \"The health science initiative focused on personalized medicine\", Luxembourg aims to participate by developing diagnostics to improve the detection and treatment of lung cancer. In line with this objective, this study made a review of evolution of lung cancer in Luxembourg from 1981 to 2008 and compared this statistics to the situation in the Nordic countries, Europe in general and the World. Incidence data of the national morphological tumour registry and mortality data of the service of statistics of the national ministry of health is depicted in charts with trend lines, in the framework of a statistical evaluation of relevant parameters. The data indicate that while male lung cancer incidence decreased in Luxembourg, the incidence in women and its mortality have doubled over the 28-year span considered. Notwithstanding this increase, the female lung cancer incidence and mortality remain low compared to the Nordic countries and Europe. Interestingly, the study also potentially suggests that the lung cancer pattern follows the smoking pattern in incidence and mortality.</p>","PeriodicalId":72476,"journal":{"name":"Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30408935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
7-year results of cell therapy in patients with severe ischemic cardiomyopathy. 重度缺血性心肌病患者细胞治疗的7年结果。
L Ekosso, C Delagardelle, G Berchem, J Beissel, D R Wagner

Background: Intracoronary infusion of autologous bone marrow cells (CTX) has been shown to improve myocardial function in post infarct patients and in patients with chronic ischemic cardiomyopathy. Long term results of CTX are unknown.

Methods and results: In this small pilot study, eleven patients with chronic ischemic cardiomyopathy and ejection fraction (EF) of 19 +/- 1% were treated with CTX and followed for 7 years. Four patients died during follow-up, all because of progressive heart failure. All patients received an implantable cardioverter defibrillator (ICD) during the course of the study but only 1 patients developed ventricular tachycardia after CTX. One patient received resynchronization therapy. The overall clinical benefit of CTX was modest (NYHA 3.0 +/- 0.1 pre and 2.5 +/- 0.2 post CTX, p= 0.06). CTX was not associated with reverse remodeling. However, left ventricular EF (19 +/- 1% pre and 18 +/- 6% post) and left ventricular end-diastolic volumes (289 +/- 71 ml pre and 294 +/- 123 ml post) remained remarkably stable over 7-year follow-up in the survivors of this very sick population.

Conclusions: During 7-year follow-up, CTX was associated with stabilization of EF and ventricular volumes but without significant clinical benefit or evidence of reverse remodeling.

背景:自体骨髓细胞(CTX)在心肌梗死后患者和慢性缺血性心肌病患者的冠脉内输注已被证明可以改善心肌功能。CTX的长期效果尚不清楚。方法和结果:在这项小规模的初步研究中,11例射血分数(EF)为19 +/- 1%的慢性缺血性心肌病患者接受CTX治疗并随访7年。4例患者在随访期间死亡,均因进行性心力衰竭。在研究过程中,所有患者都接受了植入式心律转复除颤器(ICD),但只有1例患者在CTX后出现室性心动过速。1例患者接受再同步治疗。CTX的总体临床获益一般(CTX前NYHA 3.0 +/- 0.1, CTX后NYHA 2.5 +/- 0.2, p= 0.06)。CTX与逆转重塑无关。然而,在这一严重疾病人群的幸存者中,左心室EF(前19 +/- 1%,后18 +/- 6%)和左心室舒张末期容积(前289 +/- 71 ml,后294 +/- 123 ml)在7年的随访中保持显著稳定。结论:在7年的随访中,CTX与EF和心室容量的稳定有关,但没有明显的临床益处或逆转重构的证据。
{"title":"7-year results of cell therapy in patients with severe ischemic cardiomyopathy.","authors":"L Ekosso,&nbsp;C Delagardelle,&nbsp;G Berchem,&nbsp;J Beissel,&nbsp;D R Wagner","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Intracoronary infusion of autologous bone marrow cells (CTX) has been shown to improve myocardial function in post infarct patients and in patients with chronic ischemic cardiomyopathy. Long term results of CTX are unknown.</p><p><strong>Methods and results: </strong>In this small pilot study, eleven patients with chronic ischemic cardiomyopathy and ejection fraction (EF) of 19 +/- 1% were treated with CTX and followed for 7 years. Four patients died during follow-up, all because of progressive heart failure. All patients received an implantable cardioverter defibrillator (ICD) during the course of the study but only 1 patients developed ventricular tachycardia after CTX. One patient received resynchronization therapy. The overall clinical benefit of CTX was modest (NYHA 3.0 +/- 0.1 pre and 2.5 +/- 0.2 post CTX, p= 0.06). CTX was not associated with reverse remodeling. However, left ventricular EF (19 +/- 1% pre and 18 +/- 6% post) and left ventricular end-diastolic volumes (289 +/- 71 ml pre and 294 +/- 123 ml post) remained remarkably stable over 7-year follow-up in the survivors of this very sick population.</p><p><strong>Conclusions: </strong>During 7-year follow-up, CTX was associated with stabilization of EF and ventricular volumes but without significant clinical benefit or evidence of reverse remodeling.</p>","PeriodicalId":72476,"journal":{"name":"Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30408934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of obesity-susceptibility loci (MC4R and INSIG2) on the outcome of weight loss and amelioration of co-morbidity in obese patients treated by a gastric-bypass. 肥胖易感基因座(MC4R和INSIG2)对胃旁路治疗肥胖患者体重减轻和合并症改善的影响
M Goergen, D Manzoni, V De Blasi, P Fabiano, V Poulain, L De Magistris, V Simonelli, K Dahan, J-S Azagra

Background: Genome-wide association and linkage studies have identified multiple susceptibility loci for obesity.

Objective: We hypothesized that such loci may affect weight loss and comorbidity amelioration outcomes following a gastric-bypass.

Design: A total of 200 obese patients who underwent a gastric bypass surgery were genotyped for single-nucleotide polymorphisms (SNPs) in insulin induced gene 2 (INSIG2) and melanocortin 4 receptor (MC4R) obesity genes.

Results: After a follow-up of 18 month, the patients (192) data of weight excess loss (72%) and co-morbidities (Hypertension -62- and Diabetes -39-) were analyzed and compared. 26 Patients with SNP were found (9 MC4R and 17 INSIG2). No significant differences in weight excess loss and amelioration of comorbidities were revealed.

Conclusions: The data suggest no influence of weight excess loss and amelioration of co-morbidities after gastric-bypass by genetic susceptibility.

背景:全基因组关联和连锁研究已经确定了肥胖的多个易感位点。目的:我们假设这些基因座可能影响胃旁路手术后的体重减轻和合并症改善结果。设计:共有200名接受胃旁路手术的肥胖患者进行了胰岛素诱导基因2 (INSIG2)和黑素皮质素4受体(MC4R)肥胖基因的单核苷酸多态性(snp)基因分型。结果:经过18个月的随访,对192例患者体重减轻(72%)和合并症(高血压-62-和糖尿病-39-)进行了分析和比较。发现SNP 26例(MC4R 9例,INSIG2 17例)。在体重减轻和合并症的改善方面没有显着差异。结论:这些数据表明遗传易感性对胃分流术后体重减轻和合并症的改善没有影响。
{"title":"Influence of obesity-susceptibility loci (MC4R and INSIG2) on the outcome of weight loss and amelioration of co-morbidity in obese patients treated by a gastric-bypass.","authors":"M Goergen,&nbsp;D Manzoni,&nbsp;V De Blasi,&nbsp;P Fabiano,&nbsp;V Poulain,&nbsp;L De Magistris,&nbsp;V Simonelli,&nbsp;K Dahan,&nbsp;J-S Azagra","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Genome-wide association and linkage studies have identified multiple susceptibility loci for obesity.</p><p><strong>Objective: </strong>We hypothesized that such loci may affect weight loss and comorbidity amelioration outcomes following a gastric-bypass.</p><p><strong>Design: </strong>A total of 200 obese patients who underwent a gastric bypass surgery were genotyped for single-nucleotide polymorphisms (SNPs) in insulin induced gene 2 (INSIG2) and melanocortin 4 receptor (MC4R) obesity genes.</p><p><strong>Results: </strong>After a follow-up of 18 month, the patients (192) data of weight excess loss (72%) and co-morbidities (Hypertension -62- and Diabetes -39-) were analyzed and compared. 26 Patients with SNP were found (9 MC4R and 17 INSIG2). No significant differences in weight excess loss and amelioration of comorbidities were revealed.</p><p><strong>Conclusions: </strong>The data suggest no influence of weight excess loss and amelioration of co-morbidities after gastric-bypass by genetic susceptibility.</p>","PeriodicalId":72476,"journal":{"name":"Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30408932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1